Sensei Biotherapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
02-24
Sensei Biotherapeutics Inc <snse.oq> expected to post a loss of 28 cents a share - Earnings Preview </snse.oq>
  • Sensei Biotherapeutics Inc SNSE.OQ SNSE.O is expected to show no change in quarterly revenue when it reports results on February 26 (estimated) for the period ending December 31 2024

  • ​LSEG's mean analyst estimate for Sensei Biotherapeutics Inc is for a loss of 28 cents per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Sensei Biotherapeutics Inc is $4.00​, above​ its last closing price of $0.45. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.31

-0.31

-0.29

Beat

7.2

Jun. 30 2024

-0.30

-0.29

-0.28

Beat

2.9

Mar. 31 2024

-0.27

-0.27

-0.32

Missed

-16.4​

Dec. 31 2023

-0.31

-0.31

-0.30

Beat

2.5

​​Sep. 30 2023

-0.34

-0.34

-0.28

Beat

17.4

Jun. 30 2023

-0.33

-0.33

-0.31

Beat

6.2​

Mar. 31 2023

-0.36

-0.36

-0.33

Beat

7.3

Dec. 31 2022

-0.39

-0.40

-0.40

Met

0

This summary was machine generated February 24 at 14:10 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10